David Petillo
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Renal and related cancers
- Epigenetics and DNA Methylation
- Genomics, phytochemicals, and oxidative stress
Papers in
-
- Renal and related cancers 11
- Epigenetics and DNA Methylation 6
- RNA regulation and disease 3
-
- Cancer Genomics and Diagnostics 6
- Cancer, Hypoxia, and Metabolism 6
- MicroRNA in disease regulation 4
- Co-authors
- Bin Tean Teh (26 shared papers)Kyle A. Furge (13 shared papers)Richard J. Kahnoski (11 shared papers)Chao-Nan Qian (4 shared papers)Sok Kean Khoo (14 shared papers)Ming Zhou (3 shared papers)Dan Huang (6 shared papers)Ximing J. Yang (6 shared papers)
- Journals
- Cancer Research (7 papers)PLoS Genetics (2 papers)PLoS ONE (2 papers)Cancer Cell (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesSingaporeSweden
In The Last Decade
David Petillo
34 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 783
- Molecular Biology 1.6k
- Pulmonary and Respiratory Medicine 677
- Oncology 460
- Cell Biology 126
Countries citing papers authored by David Petillo
This map shows the geographic impact of David Petillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Petillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Petillo more than expected).
Fields of papers citing papers by David Petillo
This network shows the impact of papers produced by David Petillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Petillo. The network helps show where David Petillo may publish in the future.
Co-authors
The 25 scholars most cited alongside David Petillo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 330 | |
| 2 | 2011 | 314 | |
| 3 | 2006 | 243 | |
| 4 | 2012 | 160 | |
| 5 | 2009 | 124 | |
| 6 | 2013 | 121 | |
| 7 | 2008 | 104 | |
| 8 | 2008 | 99 | |
| 9 | Inactivation of BHD in sporadic renal tumors. | 2003 | 92 |
| 10 | 2003 | 89 | |
| 11 | 2011 | 68 | |
| 12 | 2016 | 60 | |
| 13 | 2009 | 50 | |
| 14 | 2008 | 48 | |
| 15 | 2012 | 45 | |
| 16 | 2010 | 43 | |
| 17 | 2011 | 31 | |
| 18 | 2013 | 28 | |
| 19 | 2008 | 26 | |
| 20 | 2008 | 23 |
About David Petillo
David Petillo is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 34 papers that have together received 2.2k indexed citations. Recurring topics across this work include Renal and related cancers (11 papers), Renal cell carcinoma treatment (11 papers), Epigenetics and DNA Methylation (6 papers), Cancer Genomics and Diagnostics (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), MicroRNA in disease regulation (4 papers), Ferroptosis and cancer prognosis (3 papers) and RNA regulation and disease (3 papers). The work is most often cited by research in Cancer Research (783 citations), Molecular Biology (1.6k citations), Pulmonary and Respiratory Medicine (677 citations), Oncology (460 citations) and Cell Biology (126 citations). David Petillo has collaborated with scholars based in United States, Singapore and Sweden. Frequent co-authors include Bin Tean Teh, Kyle A. Furge, Richard J. Kahnoski, Chao-Nan Qian, Sok Kean Khoo, Ming Zhou, Dan Huang, Ximing J. Yang, Jindong Chen and Zhongfa Zhang. Their work appears in journals such as Cancer Research, PLoS Genetics, PLoS ONE, Cancer Cell and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.